The Application Notebook
Biotage LLC
Synthetic cannabinoids (SPICE) have become an increasing problem and an ever-changing target during drug screening. This application note describes a simple but effective method for extraction of a range of SPICE compounds and metabolites from oral fluid (neat or from a commercial collection device), with high reproducible recoveries and LLOD <1 ng/mL.
Format: ISOLUTE SLE+ 400 μL plate (part number 820-0400-P01).
Sample pre-treatment: Mix oral fluid sample (200 μL, neat or buffered from collection kit) with ammonium acetate (100 mM, pH 5, 200 μL).
Sample load: Load pre-treated sample (400 μL) onto the ISOLUTE SLE+ plate. Apply a short pulse of positive pressure and wait for 5 min.
Analyte elution: Apply ethyl acetate (2 × 700 μL). Apply short pulses of pressure and collect eluent.
Post extraction: Evaporate to dryness and reconstitute in mobile phase (500 μL).
Instrument: Agilent 1200 Liquid Handling System (Agilent Technologies, Berkshire, UK)
Column: Mac-MOD ACE Excel 2 C18-AR, 2.1 mm i.d. × 100 mm 9Mac-MOD Analytical, Chadds Ford, Pennsylvania, USA)
Mobile phase: A: 0.1%formic acid in water; B: 0.1% formic acid in methanol, Isocratic, 15% A: 85% B at 300 μL min; 9 min run time; ambient temperature
Injection volume: 10 μL
System: Applied Biosystems/MDS Sciex 4000 Q-trap mass spectrometer equipped with a Turbo Ionspray® interface (Applied Biosystems, Forster City, California, USA)
Ion source temperature: 500 °C
High (>70%), reproducible (RSD<10%) recoveries of a range of SPICE drugs and metabolites, spiked into oral fluid samples at concentrations ranging from 50 ng/mL to 1 ng/mL, were obtained using ISOLUTE SLE+ supported liquid extraction plates.
Table 1: Retention times and multiple reaction monitoring (MRM) transitions for SPICE drugs and metabolites in positive mode Turbo Ionspray.
ISOLUTE SLE+ supported liquid extraction plates can be successfully used to extract SPICE and metabolites from oral fluid samples. The method is simple, fast, and effective, and can be applied to both neat samples, and oral fluid collected in commercially available devices.
Biotage AB
Vimpelgatan 5, Uppsala, Sweden
Tel: +46 18 56 59 00 fax: +46 18 59 19 22
E-mail: info@biotage.com
Website: www.biotage.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.